Identification of an overexpressed gene, HSPA4L, the product of which can provoke prevalent humoral immune responses in leukemia patients

Experimental Hematology

Volumn 35, Issue 7, 2007, Pages 1091-1099

  Takahashi, Hidenobu ^a   Furukawa, Tatsuo ^b   Yano, Toshio ^a   Sato, Naoko ^a   Takizawa, Jun ^a   Kurasaki, Tori ^a   Abe, Takashi ^a   Narita, Miwako ^c   Masuko, Masayoshi ^b   Koyama, Satoru ^d   Toba, Ken ^a   Takahashi, Masuhiro ^c   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d Saiseikai Niigata Daini Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENTARY DNA; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70KDA PROTEIN 4 LIKE PROTEIN; LEUKEMIA ANTIGEN; MESSENGER RNA; POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE; POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLONE; CONTROLLED STUDY; DNA LIBRARY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE IDENTIFICATION; GENE OVEREXPRESSION; HSPA4L GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PNPT1 GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGICAL IDENTIFICATION OF ANTIGENS BY THE RECOMBINANT EXPRESSION CLONING; VALIDATION PROCESS; WESTERN BLOTTING;

ANTIBODY FORMATION; CELL LINE; HSP110 HEAT-SHOCK PROTEINS; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; POLYMERASE CHAIN REACTION;

EID: 34250306443     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.03.015     Document Type: Article

References (29)

1. Faderl S., Talpaz M., Estrov Z., O'Brien S., Kurzrock R., and Kantarjian H.M. The biology of chronic myeloid leukemia. N Engl J Med 341 (1999) 164-172
2. Pinilla-Ibarz J., Cathcart K., and Scheinberg D.A. CML vaccines as a paradigm of the specific immunotherapy of cancer. Blood Rev 14 (2000) 111-120
3. Molldrem J.J., Clave E., Jiang Y.Z., et al. Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units. Blood 90 (1997) 2529-2534
4. Molldrem J.J., Lee P.P., Wang C., Champlin R.E., and Davis M.M. A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia. Cancer Res. 59 (1999) 2675-2681
5. Burchert A., and Neubauer A. Interferon alpha and T-cell responses in chronic myeloid leukemia. Leuk Lymphoma 46 (2005) 167-175
6. Sahin U., Tureci O., Schmitt H., et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A 92 (1995) 11810-11813
7. Sahin U., Tureci O., and Pfreundschuh M. Serological identification of human tumor antigens. Curr Opin Immunol 9 (1997) 709-716
8. Robbins P.F., el-Gamil M., Kawakami Y., Stevens E., Yannelli J.R., and Rosenberg S.A. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54 (1994) 3124-3126
9. Chen Y.T., Scanlan M.J., Sahin U., et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A 94 (1997) 1914-1918
10. Jager E., Chen Y.T., Drijfhout J.W., et al. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 187 (1998) 265-270
11. Furukawa T., Koike T., Ying W., et al. Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis. Leukemia 8 (1994) 171-180
12. Leszczyniecka M., Kang D.C., Sarkar D., et al. Identification and cloning of human polynucleotide phosphorylase, hPNPase old-35, in the context of terminal differentiation and cellular senescence. Proc Natl Acad Sci U S A 99 (2002) 16636-16641
13. Nonoguchi K., Itoh K., Xue J.H., et al. Cloning of human cDNAs for Apg-1 and Apg-2, members of the Hsp110 family, and chromosomal assignment of their genes. Gene 237 (1999) 21-28
14. Schrick J.J., Onuchic L.F., Reeders S.T., et al. Characterization of the human homologue of the mouse Tg737 candidate polycystic kidney disease gene. Hum Mol Genet 4 (1995) 559-567
15. Zhang X., Yang H., Corydon M.J., et al. Localization of a human nucleoporin 155 gene (NUP155) to the 5p13 region and cloning of its cDNA. Genomics 57 (1999) 144-151
16. Anderson C.J., Neas B.R., Uchiumi T., and Stafford H.A. Autoantibodies to the 20-kDa ribosomal proteins: identification, characterization, and new aspects on prevalence in systemic Lupus erythematosus. Clin Immunol 98 (2001) 249-257
17. Kaneko Y., Kimura T., Nishiyama H., Noda Y., and Fujita J. Developmentally regulated expression of APG-1, a member of heat shock protein 110 family in murine male germ cells. Biochem Biophys Res Commun 233 (1997) 113-116
18. Xue J.H., Fukuyama H., Nonoguchi K., et al. Induction of Apg-1, a member of the heat shock protein 110 family, following transient forebrain ischemia in the rat brain. Biochem Biophys Res Commun 247 (1998) 796-801
19. Matsumori M., Itoh H., Toyoshima I., et al. Characterization of the 105-kDa molecular chaperone. Identification, biochemical properties, and localization. Eur J Biochem 269 (2002) 5632-5641
20. Nonoguchi K., Tokuchi H., Okuno H., et al. Expression of Apg-1, a member of the Hsp110 family, in the human testis and sperm. Int J Urol 8 (2001) 308-314
21. Ciocca D.R., and Calderwood S.K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10 (2005) 86-103
22. Bases R. Heat shock protein 70 enhanced deoxyribonucleic acid base excision repair in human leukemic cells after ionizing radiation. Cell Stress Chaperones 11 (2006) 240-249
23. Niu P., Liu L., Gong Z., et al. Overexpressed heat shock protein 70 protects cells against DNA damage caused by ultraviolet C in a dose-dependent manner. Cell Stress Chaperones 11 (2006) 162-169
24. Hosaka S., Nakatsura T., Tsukamoto H., Hatayama T., Baba H., and Nishimura Y. Synthetic small interfering RNA targeting heat shock protein 105 induces apoptosis of various cancer cells both in vitro and in vivo. Cancer Sci 97 (2006) 623-632
25. Rogers S.A., Bowen D.J., Ling M., Thomson P., Wang Z., and Lim S.H. Identification and characterization of a novel gene encoding a SEREX antigen in chronic myeloid leukaemia. Br J Haematol 119 (2002) 112-114
26. Greiner J., Ringhoffer M., Taniguchi M., et al. Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia. Int J Cancer 106 (2003) 224-231
27. Yang X.F., Wu C.J., McLaughlin S., et al. CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc Natl Acad Sci U S A 98 (2001) 7492-7497
28. Yang X.F., Wu C.J., Chen L., et al. CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells. Cancer Res 62 (2002) 5517-5522
29. Greiner J., Ringhoffer M., Taniguchi M., et al. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies. Int J Cancer 108 (2004) 704-711